Jian Yang | Neuroscience | Best Researcher Award

Published on by China Scientist

Assoc. Prof. Dr. Jian Yang | Neuroscience | Best Researcher Award

Jian Yang, Ph.D., is an Associate Professor at the School of Medicine, Shanghai University. He holds a B.S. in Chemical Technology and Engineering from Jiangsu Ocean University, an M.S. in Applied Chemistry from Sichuan University, and a Ph.D. in Medicinal Chemistry from China Pharmaceutical University, with joint research training at Massachusetts General Hospital and Harvard Medical School. His research focuses on molecular imaging probe design for early diagnosis of neurodegenerative diseases, PET tracer synthesis, and drug discovery. Dr. Yang has received funding from the China Postdoctoral Science Foundation, the National Natural Science Foundation of China, and the Natural Science Foundation of Shanghai. He actively serves as an editor and reviewer for several international journals.

Assoc. Prof. Dr. Jian Yang | Shanghai University | China

Profile

🎓Education

  • Jian Yang received his Bachelor of Science degree in Chemical Technology and Engineering from Jiangsu Ocean University, Jiangsu, China, in 2003. He pursued his Master of Science in Applied Chemistry at Sichuan University, graduating in 2006. He then completed his Ph.D. in Medicinal Chemistry at China Pharmaceutical University in 2017. During his doctoral studies, he also conducted joint research in Molecular Imaging at Massachusetts General Hospital and Harvard Medical School from 2015 to 2017.

👨‍🏫 Experience

  • Currently, Jian Yang serves as an Associate Professor at the School of Medicine, Shanghai University, a position he has held since September 2020. Prior to this, he worked as a Postdoctoral Fellow at China Pharmaceutical University from 2017 to 2020. Earlier in his career, he held industrial roles, including Manager at Nanjing JoyMed Pharmaceutical Co., Ltd. from 2010 to 2013, Group Leader at Nanjing Acesys Pharmaceutical Co., Ltd. from 2007 to 2010, and Scientist I at WuXi Apptec in Shanghai from 2006 to 2007.

🤝 Awards

  • Jian Yang has been recognized with several research grants and funding awards. These include support from the 62nd China Postdoctoral Science Foundation (No. 1600010008), the National Natural Science Foundation of China (No. 81971677), and the Natural Science Foundation of Shanghai (No. 22ZR1424400).

💡Skills and Certifications

  • He has extensive skills in molecular imaging, PET tracer synthesis, drug discovery, and new imaging technology development. Jian Yang is actively involved in editorial work, serving as a Guest Associate Editor for Frontiers in Bioengineering and Biotechnology and Frontiers in Immunology, Review Editor for Frontiers in Chemistry, and Contributing Editor for Brain-X. He also reviews for several leading journals including Analytical Chemistry, Theranostics, ACS Applied Materials & Interfaces, and Chemical Engineering Journal.

🔬 Research Focus

  • Jian Yang’s research mainly focuses on the design of molecular imaging probes for the early diagnosis of neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). He is dedicated to advancing new imaging technologies, synthesizing novel PET tracers for preclinical AD studies, and contributing to drug synthesis and drug discovery research.

🌎Conclusion

  • Dr. Jian Yang is highly suitable for the Research for Best Researcher Award. His multi-disciplinary excellence, global collaboration, translational research outcomes, and sustained publication and funding record make him a standout candidate. His contributions not only advance the scientific understanding of brain diseases but also inspire innovation in molecular diagnostics and therapeutics.

📖Publications

  •  Novel Dual-Functional Half-Curcumin Analogues as a Fluorescent and PET Probe for β-Amyloid Imaging in the Alzheimer’s Disease APP/PS1 Model
    Authors: Haijun Yang, Ke Li, Tingfang Wang, Jianguo Lin, Jian Yang
    Journal: ACS Chemical Neuroscience, 2025
  • Dual Targeting of Neuropilin-1 and Glucose Transporter for Efficient Fluorescence Imaging of Cancer
    Authors: Jianwei Zhu, Can Zhou, Jian Yang, Zhenhua Wang
    Journal: Molecular Imaging and Biology, 2025
  • Targeted Radionuclide Therapy of CLDN18.2-Positive Gastric Cancer with [131I]I-Zolbetuximab: An In Vitro and In Vivo Study
    Authors: Yang Wang, Shuhua He, Lin Ma, Zheng Li, Qingnuan Li
    Journal: Molecular Pharmaceutics, 2025

Cheng Wang | Neuroscience | Best Researcher Award

Published on by China Scientist

Prof. Cheng Wang | Neuroscience | Best Researcher Award

Research Contributions:

  • Prof. Wang has made significant advancements in understanding pediatric syncope, including establishing incidence rates, exploring circadian rhythms, and proposing biological markers and ECG indicators for differential diagnosis. These contributions have directly impacted diagnostic and therapeutic practices in pediatric cardiology.
Prof. Cheng Wang, The Second Xiangya Hospital, Central South University, China

Profile

Scopus

OrcID

🌱EARLY ACADEMIC PURSUITS

  • Cheng Wang, Ph.D., began his academic journey with a deep interest in pediatric medicine. Over the years, he developed a specific focus on pediatric cardiovascular diseases and syncope, laying the groundwork for a career dedicated to improving children’s health outcomes. His commitment to rigorous clinical training and advanced research methodologies positioned him as a leader in his field early on.

💼PROFESSIONAL ENDEAVORS

  • With an illustrious career spanning 38 years in pediatric clinical practice, Professor Wang has become a cornerstone in pediatric healthcare. He currently serves as the Deputy Chairman of the Pediatric Syncope Professional Committee under the Pediatrician Branch of the Chinese Medical Doctor Association. His professional roles have combined patient care, mentorship, and innovative research to tackle pressing issues in pediatric syncope and cardiovascular diseases.

🔬CONTRIBUTIONS AND RESEARCH FOCUS 

  • Cheng Wang’s work has significantly advanced the understanding of syncope in children. His key contributions include:
    • Epidemiology of Syncope: Determined that the incidence of syncope in children aged 2-18 is 17.37%.
    • Diagnostic Innovations: Proposed that the head-up tilt test is safe and clinically valuable for diagnosing syncope in children aged 3-5.
    • Biological Markers: Identified markers for predicting the diagnostic and therapeutic outcomes of vasovagal syncope and postural orthostatic tachycardia syndrome.
    • Demographic Studies: Highlighted the demographic factors influencing the occurrence of vasovagal syncope in children.
    • Electrocardiographic Markers: Introduced ECG markers to differentiate between vasovagal syncope, epilepsy, and psychogenic pseudosyncope in pediatric patients.

🌍IMPACT AND INFLUENCE

  • Professor Wang’s work has been instrumental in shaping pediatric cardiovascular research and clinical protocols. His findings on the circadian rhythm of syncope in children and the demographic patterns of vasovagal syncope have influenced guidelines in pediatric care globally. He has contributed to multi-center clinical research projects, such as developing predictive models for beta-adrenergic receptor blocker efficacy in treating pediatric syncope.

📚ACADEMIC CITES 

  • Professor Cheng Wang has published 52 papers in high-impact SCI journals, with a citation index of 518 and an h-index of 11. These metrics underscore the reach and influence of his research, making him a respected voice in pediatric cardiovascular studies.

🌟LEGACY AND FUTURE AND CONTRIBUTIONS

  • Through his books, including Handbook of Pediatric Cardiovascular Diseases and Syncope in Children, Professor Wang has ensured his knowledge is accessible to a global audience. As a guest editor for Children (Basel) and a leader in his field, he continues to shape the future of pediatric medicine. His ongoing projects and mentorship of upcoming professionals signify a legacy of innovation and impact.

📄Publications

  • The association between patent foramen ovale and unexplained syncope in pediatric patients
    Authors: Zou, R.; Wang, S.; Liu, P.; Wang, Y.; Wang, C.
    Journal: Italian Journal of Pediatrics, 2024, 50(1), 2
  • Relationship between syncopal symptoms and head-up tilt test modes
    Authors: Wang, S.; Peng, Y.; Wang, Y.; Zou, R.; Wang, C.
    Journal: Cardiology in the Young, 2024, 34(7), pp. 1583–1588
  • Factors affecting the syncopal episodes in pediatric vasovagal syncope
    Authors: Wang, S.; Peng, Y.; Liu, P.; Zou, R.; Wang, C.
    Journal: Neurological Sciences, 2024 (In Press)
  • Clinical and Genetic Characteristics of Early-Onset Lung Adenocarcinoma in a Large Chinese Cohort
    Authors: Xie, S.; Hu, Q.; Wu, Z.; Yu, F.; Peng, M.
    Journal: Annals of Thoracic Surgery, 2024
  • Relationship between hemodynamic type and syncopal symptoms in pediatric vasovagal syncope
    Authors: Wang, S.; Peng, Y.; Zou, R.; Li, F.; Wang, C.
    Journal: European Journal of Pediatrics, 2024, 183(1), pp. 179–184